Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Immune cell study prompts new approach to tackling infections
Oxygen levels in the body can have a profound effect on the way cells behave.

Oxygen level affects how cells behave

A new study by the University of Edinburgh has found that oxygen levels in the body can have a profound effect on the way cells behave.

The research, published in the journal Science Immunology, could pave the way to new treatments that target the immune response to infection.

In the study of mice, researchers found that bacteria infections have vastly different outcomes depending on the level of oxygen in the body when infection takes hold.  

In mice that had low levels of oxygen in the body when the virus took hold, the immune system launched a massive overreaction. Fatal illness occurred, even though the bacteria had cleared from the body.

If the mice had low oxygen levels before the virus took hold, the researchers found that this protects the body from illness, without preventing it from fighting the bacteria.

If human cells react in the same way, researchers say that oxygen sensing mechanisms could be ‘tweaked’ in order to tackle infections.

It is hoped that the findings will help people suffering from chronic lung conditions, such as emphysema. These patients often have low levels of oxygen in their body and are more susceptible to infection.

“We are excited by our observation that oxygen levels can regulate immune cell responses to infection,” commented Dr Sarah Walmsley, of the MRC Centre for Inflammation Research at the University of Edinburgh.

“Targeting these pathways could have the potential to improve outcomes from infections where oxygen is limited.”

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.